- OSA predicted earning capacity of $5 billion per annum sales after approval...
- Another psychedelic medicine trial into a significant under-treated indication has been largely advanced with further details to be released to the market as soon as appropriate...
amazing the market cap still under 200 milly with so much in the pipeline